Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers
Year: 2012
Type: article
Study design: Observational Study
Authors: Swedish Breast Cancer Study, Sweden (SWE-BRCA), Kristen N. Stevens, HEreditary Breast and Ovarian Cancer Group Netherlands (HEBON), CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella (CONSIT Team), kConFab, Xianshu Wang, Zachary Fredericksen, Vernon S. Pankratz, Mark H. Greene, Irene L. Andrulis, Mads Thomassen, Maria Caligo, Katherine L. Nathanson, Anna Jakubowska, Ana Osorio, Ute Hamann, Andrew K. Godwin, Dominique Stoppa-Lyonnet, Melissa Southey, Saundra S. Buys, Christian F. Singer, Thomas V. O. Hansen, Adalgeir Arason, Kenneth Offit, Marion Piedmonte, Marco Montagna, Evgeny Imyanitov, Laima Tihomirova, Lara Sucheston, Mary Beattie, Susan L. Neuhausen, Csilla I. Szabo, Jacques Simard, Amanda B. Spurdle, Sue Healey, Xiaoqing Chen, Timothy R. Rebbeck, Douglas F. Easton, Georgia Chenevix-Trench, Antonis C. Antoniou, Fergus J. Couch
Institutions: Mayo Clinic, National Institutes of Health, Peter MacCallum Cancer Centre, National Cancer Institute, Cancer Care Ontario, Odense University Hospital, University of Pisa, Azienda Ospedaliera Universitaria Pisana, Abramson Cancer Center, University of Pennsylvania, Mount Sinai Hospital, University of Toronto, International Hereditary Cancer Center, Pomeranian Medical University, Spanish National Cancer Research Centre, German Cancer Research Center, University of Kansas Medical Center, Inserm, Université Paris Descartes, Institut Curie, The University of Melbourne, Centre for Biomedical Network Research on Rare Diseases, University of Utah, Huntsman Cancer Institute, Comprehensive Cancer Center Vienna, Medical University of Vienna, Copenhagen University Hospital, Rigshospitalet, National University Hospital of Iceland, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Istituto Oncologico Veneto, University of Iceland, Institute of Oncology NN Petrov, Latvian Biomedical Research and Study Centre, University of California, San Francisco, Beckman Research Institute, University of Delaware, Centre hospitalier universitaire de Québec, Centre hospitalier de l'Université Laval, Université Laval, QIMR Berghofer Medical Research Institute, Belfast City Hospital, University of Cambridge
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
Awards: Australian Breast Cancer Family Registry, A genome-wide association study for breast cancer in BRCA1 mutation carriers, G1232765841, G1784276273, Gynecologic Oncology Group Specimen Banking, G2325870751, Ontario Familial Breast Cancer Registry, G236237718, Northern California Cooperative Family Registry for Breast Cancer, Prophytactic surgery in carriers of BRCA 1/2 mutations, G2567900542, G2657569366, G3355877513, G3493320632, G3700984039, G380538514, Genetic epidemiology of cell division regulation in breast cancer, GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER, G4169063343, Mayo Cancer Genetic Epidemiology Training Program, Metropolitan New York Regisry of Breast Cancer Families, Gynecologic Oncology Group, GYNECOLOGIC ONCOLOGY GROUP, G5865683244, G5950516432, G6279653796, Philadelphia Breast Cancer Family Registry, Clinical Cancer Genetics Community Network: A Sustainable Research Partnership, Radiation biology training grant, Utah Breast Cancer Family Registry, Mayo Clinic Breast Cancer SPORE, Genetic Epidemiology of Breast Cancer: BRCA1 and BRCA2
OpenAlex ID: W2008478049